ORIGINAL RESEARCH
Published on 18 Apr 2024
Interleukin-2 is required for NKp30-dependent NK cell cytotoxicity by preferentially regulating NKp30 expression
doi 10.3389/fimmu.2024.1388018
- 4,686 views
- 7 citations
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in NK Cell Modifications to Advance their Anti-tumor Activities: Volume II
Community Series in NK Cell Modifications to Advance their Anti-tumor Activities: Volume II
8,976
Total downloads
29k
Total views and downloads
Articles
REVIEW
Published on 18 Jul 2023
Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond
doi 10.3389/fimmu.2023.1192907
- 12,705 views
- 36 citations
ORIGINAL RESEARCH
Published on 03 May 2023
Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies
doi 10.3389/fimmu.2023.1130442
- 4,579 views
- 19 citations
ORIGINAL RESEARCH
Published on 09 Dec 2022
Potent immunomodulatory and antitumor effect of anti-CD20-IL2no-alpha tri-functional immunocytokine for cancer therapy
doi 10.3389/fimmu.2022.1021828
- 2,373 views
- 3 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore